Show simple item record

dc.contributor.authorCook, A
dc.contributor.authorEmbleton, A
dc.contributor.authorJayson, Gordon C
dc.contributor.authorKaplan, R
dc.contributor.authorKristensen, G
dc.contributor.authorParmar, M
dc.contributor.authorPfisterer, J
dc.contributor.authorPujade-Lauraine, E
dc.contributor.authorOza, A
dc.contributor.authorPerren, T
dc.date.accessioned2017-11-23T21:31:27Z
dc.date.available2017-11-23T21:31:27Z
dc.date.issued2017-09
dc.identifier.citation961P ICON7: ovarian cancer, platinum second-line chemotherapy and overall survival. 2017, 28(suppl_5): Ann Oncolen
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.doi10.1093/annonc/mdx372.032
dc.identifier.urihttp://hdl.handle.net/10541/620696
dc.language.isoenen
dc.relation.urlhttp://academic.oup.com/annonc/article/doi/10.1093/annonc/mdx372.032/4109046/961PICON7-Ovarian-cancer-platinum-secondlineen
dc.rightsArchived with thanks to Annals of Oncologyen
dc.title961P ICON7: ovarian cancer, platinum second-line chemotherapy and overall survival.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMRC clinical trials unit, Institute of Clinical Trials and Methodology-UCL, Londonen
dc.identifier.journalAnnals of Oncologyen


This item appears in the following Collection(s)

Show simple item record